Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2026-01-13 @ 12:41 AM
Study NCT ID:
NCT01476332
Status:
COMPLETED
Last Update Posted:
2012-05-17
First Post:
2011-11-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety, Tolerability and Pharmacokinetics of 0.5% and 2.5% Cis-UCA Eye Drops in Adult Healthy Volunteers (Phase I)
Sponsor:
Laurantis Pharma, Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-11
Start Date Type:
None
Primary Completion Date:
2012-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-11-10
First Submit QC Date:
None
Study First Post Date:
2011-11-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-05-15
Last Update Post Date:
2012-05-17
Last Update Post Date Type:
ESTIMATED